Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;90:2213-2224

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koumi, S.
Right arrow Articles by Wasserstrom, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koumi, S.
Right arrow Articles by Wasserstrom, J. A.

Circulation, Vol 90, 2213-2224, Copyright © 1994 by American Heart Association


ARTICLES

Alterations in muscarinic K+ channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts

S Koumi, CE Arentzen, CL Backer and JA Wasserstrom
Department of Medicine (Reingold ECG Center), Northwestern University School of Medicine, Chicago, IL 60611.

BACKGROUND--A variety of previous studies have demonstrated reduced diastolic potential and electrical activity in atrial specimens from patients with heart disease. Although K+ channels play a major role in determining resting membrane potential and repolarization of the action potential, little is known about the effects of preexisting heart disease on human atrial K+ channel activity. METHODS AND RESULTS--We characterized the inwardly rectifying K+ channel (IKI) and the muscarinic K+ channel [IK(ACh)] in atrial myocytes isolated from patients with heart failure (HF) and compared electrophysiological characteristics with those from donors (control) by the patch-clamp technique. Resting membrane potentials of isolated atrial myocytes from HF were more depolarized (-51.1 +/- 9.7 mV, mean +/- SD, n = 30 patients) than those from donors (-73.0 +/- 7.2 mV, n = 4 patients, P < .001). The action potential duration in HF was longer than that in donors. Although acetylcholine (ACh) shortened the action potential, reduced the overshoot, and hyperpolarized the atrial cell membrane in HF, these effects were attenuated compared with those observed in donors. The whole-cell membrane current slope conductance in HF was small, the reversal potential was more positive, and the sensitivity to ACh was less compared with donors. In single-channel recordings from cell-attached patches, IK1 channel conductance and gating characteristics were the same in HF and donor atria. When ACh was included in the pipette solution, IK(ACh) was activated in both groups. Single-channel slope conductance of IK(ACh) averaged 42 +/- 3 pS (n = 28) in HF and 44 +/- 2 pS (n = 4) in donors, and mean open lifetime was 1.3 +/- 0.3 milliseconds (n = 24) in HF and 1.5 +/- 0.4 milliseconds (n = 4) in donors. These values were virtually identical in the two groups (not significantly different, NS), although both single IK1 and IK(ACh) channel densities were less in HF. Channel open probability of IK(ACh) was also less in HF (4.0 +/- 1.2%, n = 24) than in donors (6.8 +/- 1.1%, n = 3, P < .01). The concentration of ACh at half-maximal activation was 0.11 mumol/L in HF and 0.03 mumol/L in donors. In excised inside-out patches, IK(ACh) from HF required higher concentrations of GTP and GTP gamma S to activate the channel compared with donors. These results suggest a reduced IK(ACh) channel sensitivity to M2 cholinergic receptor-linked G protein (Gi) in HF compared with donors. CONCLUSIONS--Atrial myocytes isolated from failing human hearts exhibited a lower resting membrane potential and reduced sensitivity to ACh compared with donor atria. Whole-cell and single-channel measurements suggest that these alterations are caused by reduced IK1 and IK(ACh) channel density and reduced IK(ACh) channel sensitivity to Gi-mediated channel activation in HF.


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
A. Bye, M. Langaas, M. A. Hoydal, O. J. Kemi, G. Heinrich, L. G. Koch, S. L. Britton, S. M. Najjar, O. Ellingsen, and U. Wisloff
Aerobic capacity-dependent differences in cardiac gene expression
Physiol Genomics, October 8, 2008; 33(1): 100 - 109.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Tanaka, S. Zlochiver, Karen. L. Vikstrom, M. Yamazaki, J. Moreno, M. Klos, Alexey. V. Zaitsev, R. Vaidyanathan, D. S. Auerbach, S. Landas, et al.
Spatial Distribution of Fibrosis Governs Fibrillation Wave Dynamics in the Posterior Left Atrium During Heart Failure
Circ. Res., October 12, 2007; 101(8): 839 - 847.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Cheng, K. Kinard, R. Rajamani, and M. C. Sanguinetti
Molecular Mapping of the Binding Site for a Blocker of Hyperpolarization-Activated, Cyclic Nucleotide-Modulated Pacemaker Channels
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Dobrev, A. Friedrich, N. Voigt, N. Jost, E. Wettwer, T. Christ, M. Knaut, and U. Ravens
The G Protein-Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation
Circulation, December 13, 2005; 112(24): 3697 - 3706.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Baba, T. Yoshikawa, Y. Fukuda, T. Sugiyama, M. Shimada, M. Akaishi, K. Tsuchimoto, S. Ogawa, and M. Fu
Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy
Eur. Heart J., July 1, 2004; 25(13): 1108 - 1115.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Fernandez-Velasco, N. Goren, G. Benito, J. Blanco-Rivero, L. Bosca, and C. Delgado
Regional distribution of hyperpolarization-activated current (If) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts
J. Physiol., December 1, 2003; 553(2): 395 - 405.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. F Bosch and S. Nattel
Cellular electrophysiology of atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 259 - 269.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Dobrev, E. Wettwer, A. Kortner, M. Knaut, S. Schuler, and U. Ravens
Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 397 - 404.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Dobrev, E. Graf, E. Wettwer, H. M. Himmel, O. Hala, C. Doerfel, T. Christ, S. Schuler, and U. Ravens
Molecular Basis of Downregulation of G-Protein-Coupled Inward Rectifying K+ Current (IK,ACh) in Chronic Human Atrial Fibrillation: Decrease in GIRK4 mRNA Correlates With Reduced IK,ACh and Muscarinic Receptor-Mediated Shortening of Action Potentials
Circulation, November 20, 2001; 104(21): 2551 - 2557.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Allessie, P. A. Boyden, A. J. Camm, A. G. Kleber, M. J. Lab, M. J. Legato, M. R. Rosen, P. J. Schwartz, P. M. Spooner, D. R. Van Wagoner, et al.
Pathophysiology and Prevention of Atrial Fibrillation
Circulation, February 6, 2001; 103(5): 769 - 777.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. Nattel and D. Li
Ionic Remodeling in the Heart : Pathophysiological Significance and New Therapeutic Opportunities for Atrial Fibrillation
Circ. Res., September 15, 2000; 87(6): 440 - 447.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Dobrev, E. Wettwer, H. M. Himmel, A. Kortner, E. Kuhlisch, S. Schuler, W. Siffert, and U. Ravens
G-Protein {beta}3-Subunit 825T Allele Is Associated With Enhanced Human Atrial Inward Rectifier Potassium Currents
Circulation, August 8, 2000; 102(6): 692 - 697.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Li, P. Melnyk, J. Feng, Z. Wang, K. Petrecca, A. Shrier, and S. Nattel
Effects of Experimental Heart Failure on Atrial Cellular and Ionic Electrophysiology
Circulation, June 6, 2000; 101(22): 2631 - 2638.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. K. Doshi and B. N. Singh
Reviews: Pure Class III Antiarrhythmic Drugs: Focus on Dofetilide
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 237 - 247.
[PDF]


Home page
HypertensionHome page
M. Pelat, P. Verwaerde, C. Merial, J. Galitzky, M. Berlan, J.-L. Montastruc, and J.-M. Senard
Impaired Atrial M2-Cholinoceptor Function in Obesity-Related Hypertension
Hypertension, November 1, 1999; 34(5): 1066 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. W. Veldkamp, B. de Jonge, and A. C.G. van Ginneken
Decreased inward rectifier current in adult rabbit ventricular myocytes maintained in primary culture: a single-channel study
Cardiovasc Res, May 1, 1999; 42(2): 424 - 433.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Courtemanche, R. J. Ramirez, and S. Nattel
Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model
Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H301 - H321.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Yue, J. Feng, R. Gaspo, G.-R. Li, Z. Wang, and S. Nattel
Ionic Remodeling Underlying Action Potential Changes in a Canine Model of Atrial Fibrillation
Circ. Res., October 19, 1997; 81(4): 512 - 525.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. O. Sowell, C. Ye, D. A. Ricupero, S. Hansen, S. J. Quinn, P. M. Vassilev, and R. M. Mortensen
Targeted inactivation of alpha i2 or alpha i3 disrupts activation of the cardiac muscarinic K+ channel, IK+Ach, in intact cells
PNAS, July 22, 1997; 94(15): 7921 - 7926.
[Abstract] [Full Text] [PDF]